Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
JAMA Network Open
|
February 21, 2022
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
Csilla Várnai, Claire Palles, Roland Arnold, et al.
Gut
|
March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
Dan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Brain Communications
|
July 3, 2026
Late-onset epileptic spasms: presentation, aetiology and outcome
Sameer Dal, Emma Macdonald-Laurs, Simone Mandelstam, et al.
Journal of the National Cancer Institute
|
August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Anna D Wagner, Axel Grothey, Thierry Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
Enric Domingo, Caroline Kelly, Jennifer Hay, et al.
JAMA Oncology
|
October 2, 2025
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical Trials
Alessandro Pastorino, Heshan Liu, Levi Pederson, et al.
Journal of the National Cancer Institute
|
January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
Victoria Gray, Sarah Briggs, Claire Palles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
Claire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
JAMA Network Open
|
February 21, 2022
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
Csilla Várnai, Claire Palles, Roland Arnold, et al.
Gut
|
March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
Dan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Brain Communications
|
July 3, 2026
Late-onset epileptic spasms: presentation, aetiology and outcome
Sameer Dal, Emma Macdonald-Laurs, Simone Mandelstam, et al.
Journal of the National Cancer Institute
|
August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Anna D Wagner, Axel Grothey, Thierry Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
Enric Domingo, Caroline Kelly, Jennifer Hay, et al.
JAMA Oncology
|
October 2, 2025
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical Trials
Alessandro Pastorino, Heshan Liu, Levi Pederson, et al.
Journal of the National Cancer Institute
|
January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
Victoria Gray, Sarah Briggs, Claire Palles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
Claire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
Page
of 6